(Q35838378)

10 August 2017

1 reference

title

Drug treatment of intermittent claudication (English)

1 reference

10 August 2017

1 reference

Douglas Jacoby

1

1 reference

10 August 2017

Emile R Mohler

series ordinal

2

1 reference

10 August 2017

publication date

1 January 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

64

1 reference

10 August 2017

issue

15

1 reference

10 August 2017

page(s)

1657-1670

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200464150-00004

10 August 2017

exact match

0 references

cites work

Beraprost for the treatment of intermittent claudication

1 reference

12 December 2020

Gingko biloba extract EGb 761 and pentoxifylline in intermittent claudication. Secondary analysis of the clinical effectiveness

1 reference

12 December 2020

Inhibitors of cyclic nucleotide phosphodiesterase isozymes type-III and type-IV suppress mitogenesis of rat mesangial cells

1 reference

12 December 2020

Cilostazol, a novel cyclic AMP phosphodiesterase inhibitor, prevents reocclusion after coronary arterial thrombolysis with recombinant tissue-type plasminogen activator

1 reference

12 December 2020

Effect of the novel antiplatelet agent cilostazol on plasma lipoproteins in patients with intermittent claudication

1 reference

12 December 2020

A new study demonstrates the efficacy of naftidrofuryl in the treatment of intermittent claudication. Findings of the Naftidrofuryl Clinical Ischemia Study (NCIS).

1 reference

12 December 2020

Effects of a single local administration of cilostazol on neointimal formation in balloon-injured rat carotid artery

1 reference

12 December 2020

Cyclic nucleotides and phosphodiesterases in platelets

1 reference

12 December 2020

Effect of Cilostazol, a Cyclic AMP Phosphodiesterase Inhibitor, on the Proliferation of Rat Aortic Smooth Muscle Cells in Culture

1 reference

12 December 2020

Adenoviral-mediated gene transfer of vascular endothelial growth factor in critical limb ischemia: safety results from a phase I trial

1 reference

12 December 2020

Management of peripheral arterial disease (PAD). TransAtlantic Inter-Society Consensus (TASC)

1 reference

12 December 2020

The effect of naftidrofuryl on intermittent claudication: a meta-analysis

1 reference

12 December 2020

Evidence-based symptom relief of intermittent claudication: efficacy and safety of cilostazol

1 reference

12 December 2020

Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial

1 reference

12 December 2020

Ginkgo biloba extract for the treatment of intermittent claudication: a meta-analysis of randomized trials

1 reference

12 December 2020

Effect of glutathione infusion on leg arterial circulation, cutaneous microcirculation, and pain-free walking distance in patients with peripheral obstructive arterial disease: a randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Effect of propionyl-L-carnitine on quality of life in intermittent claudication

1 reference

12 December 2020

Effects of cilostazol, a selective cAMP phosphodiesterase inhibitor on the contraction of vascular smooth muscle

1 reference

12 December 2020

Peripheral arterial disease detection, awareness, and treatment in primary care

1 reference

12 December 2020

Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review

1 reference

12 December 2020

A meta-analysis of randomized, double-blind, placebo-controlled studies of the effect of buflomedil on intermittent claudication.

1 reference

12 December 2020

Cilostazol: treatment of intermittent claudication

1 reference

12 December 2020

Can claudication be improved with medication?

1 reference

12 December 2020

Pharmacological management of intermittent claudication: a meta-analysis of randomised trials

1 reference

12 December 2020

Comparative evaluation of the effectiveness of buflomedil and pentoxifylline in patients with arterial occlusive disease

1 reference

12 December 2020

Prostanoids in the treatment of intermittent claudication--a meta-analysis

1 reference

12 December 2020

A critical appraisal of ticlopidine, a new antiplatelet agent. Effectiveness and clinical indications for prophylaxis of atherosclerotic events

1 reference

12 December 2020

Naftidrofuryl in arterial occlusive disease. Controlled multicenter double-blind study with oral administration

1 reference

12 December 2020

Superiority of L-propionylcarnitine vs L-carnitine in improving walking capacity in patients with peripheral vascular disease: an acute, intravenous, double-blind, cross-over study

1 reference

12 December 2020

Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials

1 reference

12 December 2020

Multicenter double-blind study of ticlopidine in the treatment of intermittent claudication and the prevention of its complications

1 reference

12 December 2020

Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty

1 reference

12 December 2020

Naked plasmid DNA encoding fibroblast growth factor type 1 for the treatment of end-stage unreconstructible lower extremity ischemia: preliminary results of a phase I trial

1 reference

12 December 2020

Restoring vascular nitric oxide formation by l-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease

1 reference

12 December 2020

Blood viscosity during long-term treatment with ticlopidine in patients with intermittent claudication. A double-blind study

1 reference

12 December 2020

Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia

1 reference

12 December 2020

Effect of cilostazol, a cAMP phosphodiesterase inhibitor, on nitric oxide production by vascular smooth muscle cells

1 reference

12 December 2020

Shear-induced platelet aggregation in normal subjects and stroke patients

1 reference

12 December 2020

Cilostazol: a novel treatment option in intermittent claudication.

1 reference

12 December 2020

Trental 400 in the treatment of intermittent claudication: results of long-term, placebo-controlled administration.

1 reference

12 December 2020

Comparative study of antiplatelet drugs in vitro: distinct effects of cAMP-elevating drugs and GPIIb/IIIa antagonists on thrombin-induced platelet responses

1 reference

12 December 2020

Meta-analysis of some results of clinical trials on sulodexide therapy in peripheral occlusive arterial disease

1 reference

12 December 2020

Ticlopidine in the treatment of intermittent claudication: a 21-month double-blind trial.

1 reference

12 December 2020

A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial

1 reference

12 December 2020

Analysis of the cilostazol safety database

1 reference

12 December 2020

The prevalence of peripheral arterial disease in a defined population

1 reference

12 December 2020

Comparison of Safety and Efficacy of Buflomedil and Naftidrofuryl in the Treatment of Intermittent Claudication

1 reference

12 December 2020

Inhibition of shear stress-induced platelet aggregation by cilostazol, a specific inhibitor of cGMP-inhibited phosphodiesterase, in vitro and ex vivo

1 reference

12 December 2020

Effects of cilostazol on resting ankle pressures and exercise-induced ischemia in patients with intermittent claudication

1 reference

12 December 2020

Gene therapy techniques for peripheral arterial disease

1 reference

12 December 2020

Buflomedil for intermittent claudication.

1 reference

12 December 2020

Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC).

1 reference

12 December 2020

Effect of cilostazol in preventing restenosis after percutaneous transluminal coronary angioplasty

1 reference

12 December 2020

Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial

1 reference

12 December 2020

Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients

1 reference

12 December 2020

Propionyl-L-carnitine improves exercise performance and functional status in patients with claudication

1 reference

12 December 2020

Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease

1 reference

12 December 2020

Gene therapy progress and prospects: therapeutic angiogenesis for limb and myocardial ischemia

1 reference

12 December 2020

Pharmacotherapy for peripheral arterial disease: emerging therapeutic options

1 reference

12 December 2020

A comparison of cilostazol and pentoxifylline for treating intermittent claudication

1 reference

12 December 2020

Potential emerging therapeutic strategies to prevent restenosis in the peripheral vasculature

1 reference

12 December 2020

Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy

1 reference

12 December 2020

European multicenter study on propionyl-L-carnitine in intermittent claudication.

1 reference

12 December 2020

Comparative evaluation of pentoxifylline, buflomedil, and nifedipine in the treatment of intermittent claudication of the lower limbs

1 reference

12 December 2020

Redefining the treatment of peripheral artery disease. Role of percutaneous revascularization

1 reference

12 December 2020

A long-term study of policosanol in the treatment of intermittent claudication

1 reference

12 December 2020

Naftidrofuryl in chronic arterial disease. Results of a six month controlled multicenter study using Naftidrofuryl tablets 200 mg

1 reference

12 December 2020

Naftidrofuryl in quality of life (NIQOL). A Belgian study.

1 reference

12 December 2020

The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava

1 reference

12 December 2020

Propionyl-l-carnitine in intermittent claudication: Double-blind, placebo-controlled, dose titration, multicenter study

1 reference

12 December 2020

Pentoxifylline in the treatment of intermittent claudication of the lower limbs

1 reference

12 December 2020

On the assessment of the efficacy of pentoxifylline (Trental)

1 reference

12 December 2020

Long-term effects of ticlopidine on lower limb blood flow, ankle/brachial index and symptoms in peripheral arteriosclerosis. A double-blind study. The STIMS Group in Lund. Swedish Ticlopidine Multicenter Study

1 reference

12 December 2020

Sulodexide in the treatment of intermittent claudication. Results of a randomized, double-blind, multicentre, placebo-controlled study

1 reference

12 December 2020

10.2165/00003495-200464150-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

10 August 2017

1035325425

0 references

1 reference